Peter J Wilkinson
CIK 1398138 · SVP, Chief Accounting Officer · last filed 2026-08-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$579.9K
Companies
2
Total Filings
48
Lifetime Open-Market Net
-$4.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LH | SVP, Chief Accounting Officer | 1,770 | $327.61 | $579.9K | -$3.73M | 38 | 2026-08-05 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | VP of Fin./Chief Acctg. Off. | 828 | — | — | -$299.5K | 10 | 2009-01-05 |
Recent Filings · Page 2 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-13 | LH | Mixed | +82 | -$10.1K | EDGAR |
| 2025-02-10 | LH | Mixed | +175 | -$22.7K | EDGAR |
| 2024-05-01 | LH | Sell (S) | −2,439 | -$498.4K | EDGAR |
| 2024-03-29 | LH | Mixed | +2,185 | -$193.6K | EDGAR |
| 2024-02-13 | LH | Mixed | +80 | -$9.8K | EDGAR |
| 2024-02-08 | LH | Mixed | +88 | -$10.3K | EDGAR |
| 2024-02-06 | LH | Mixed | +86 | -$10.0K | EDGAR |
| 2023-11-20 | LH | Sell (S) | −1,384 | -$291.6K | EDGAR |
| 2023-08-03 | LH | Mixed | +39 | -$3.6K | EDGAR |
| 2023-07-05 | LH | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.